Fair Market Value and Hospital Physician Relationships Kevin - - PowerPoint PPT Presentation

fair market value and hospital physician relationships
SMART_READER_LITE
LIVE PREVIEW

Fair Market Value and Hospital Physician Relationships Kevin - - PowerPoint PPT Presentation

Fair Market Value and Hospital Physician Relationships Kevin Walker Andrew D. Kloeckner CBIZ Baird Holm LLP kwalker@cbiz.com akloeckner@bairdholm.com 816.945.5598 402.636.8222 Agenda Why Is FMV Important? Roles in Determining


slide-1
SLIDE 1

Fair Market Value and Hospital – Physician Relationships

Andrew D. Kloeckner Baird Holm LLP akloeckner@bairdholm.com 402.636.8222 Kevin Walker CBIZ kwalker@cbiz.com 816.945.5598

slide-2
SLIDE 2

Agenda

  • Why Is FMV Important?
  • Roles in Determining FMV
  • Current State - What Is FMV?
  • Proposed Regulatory Changes
  • Best Practices
slide-3
SLIDE 3

Why Is FMV Important?

  • Stark
  • Anti-Kickback
  • Tax Exemption/Governmental Status
slide-4
SLIDE 4

Stark

  • A financial relationship with a referring

physician must meet an exception to the Stark Law

  • Relevant exceptions require:

– Identifiable services – Consistent with FMV (all compensation) – Not determined in a manner that takes into account, directly or indirectly, the volume or value of referrals by the physician – Remuneration would be commercially reasonable even if no referrals were made

slide-5
SLIDE 5

Commercial Reasonableness

  • It’s not just FMV
  • Stark definition of “commercially

reasonable”

– Makes commercial sense in absence of referrals – A reasonable entity, similar type and size – A reasonable physician of similar scope and specialty (But see proposed regulatory changes…discussed later)

slide-6
SLIDE 6

Stark

  • Penalties: Significant penalties for

violation

– Refund of all Medicare claims due to referrals from improper relationship – False Claims Act liability (treble damages) – Stark CMP of $24,253 per claim – Potential exclusion from the Medicare program

slide-7
SLIDE 7

National Enforcement Environment

  • Unprecedented number and size of recent

settlements involving compensation issues

  • All start as qui tam (whistleblower) cases

– Typically not the result of government investigations – Disgruntled employees or physicians – Whistleblower can earn 15-25% if U.S. intervenes; 25-30% if not, plus attorney fees and costs

slide-8
SLIDE 8
  • Tuomey (South Carolina)

– $237 million judgment; $72.4 million settlement – $1 million settlement for CEO

  • Citizen’s Medical Center (Victoria, Texas)

– $21,750,000 settlement (whistleblowers received almost $6 million) (Qui tam brought by three cardiologists) – Physician bonuses and compensation in excess

  • f FMV

National Enforcement Environment

slide-9
SLIDE 9

National Enforcement Environment

  • OIG Fraud Alert, June 19, 2015

– Focus on physicians receiving inappropriate medical director payments

  • Yates Memo, September 9, 2015

– Focus on individual accountability, no longer just secondary targets

slide-10
SLIDE 10

Anti-Kickback Statute

  • Rule: Compensation may not induce
  • r encourage referrals of Medicare

and Medicaid business to the hospital

– Intent based statute

– But, intent can be inferred

– “One purpose test” – Could have 99 purposes for remuneration that are not related to referrals, but if reason #100 is to induce or reward referrals, then the statute is violated

slide-11
SLIDE 11

Anti-Kickback Statute

  • Criminal statute

– 10 years or $100,000 fine per claim or both – Civil monetary penalties - $100,000 per claim

  • Subject to potential FCA/qui tam suits
  • Voluntary safe harbors
slide-12
SLIDE 12

IRS Issues

  • Rules:

– Earnings cannot inure to the benefit of a private individual – Compensation must be "reasonable"

  • Penalties:

– Potential intermediate sanctions/excise tax – Potential loss of 501(c)(3) status

slide-13
SLIDE 13

IRS Issues

  • Compensation - not excessive
  • Process is important

– Independent board – Subject to conflict of interest policy – Based on compensation studies of comparables

  • Ongoing compliance
  • No incentive to reduce charitable

services/benefit

  • Not a joint venture or distribution of profits

– Bonuses based on profitability can be a problem

slide-14
SLIDE 14

FMV Roles & Responsibilities

  • Hospital Health System Leadership

– Obtain FMV guidance from Legal Counsel and Valuator – Responsible for commercially reasonable decision

  • Legal Counsel

– Compliance – Not FMV experts – Commercial reasonableness guidance

  • Valuator

– Ensure amounts are FMV – Commercial reasonableness guidance

slide-15
SLIDE 15

The Three Hats For Analyzing Transactions

  • Transaction Design and Implementation
  • Best Practices
  • Risk Tolerance
  • Relative Benefits
  • Compliance Review
  • Defensible Position
  • Appropriate Corrections
  • Litigation Defense - Retrospective
  • Risk Tolerance
  • Reasonable Defenses
slide-16
SLIDE 16

What is FMV?

  • Fair Market Value is:

– FACTS and CIRCUMSTANCES based – A defendable position – A range, not an exact number

  • Each transaction takes on a life of its
  • wn

– Know your facts

slide-17
SLIDE 17

What is FMV?

  • Typical scenarios

– Practice acquisitions – Professional services

slide-18
SLIDE 18

What is FMV?

  • Practice Acquisitions

– Asset Approach – Market Approach – Income Approach

slide-19
SLIDE 19

Practice Acquisitions

  • For the physician practice to have value in excess
  • f net assets, the accepted method of

demonstrating value is through a Discounted Cash Flow, reflecting post- acquisition compensation

  • We anticipate compensation offers in excess of

current compensation will result in post-transaction losses

  • Result is normally the application or use of the Asset

Approach

19

slide-20
SLIDE 20

Practice Acquisitions

  • Asset Approach

– Determine which assets will be acquired

  • Supplies inventory
  • Furniture, fixtures and equipment
  • Trained and assembled workforce

– Assets not typically acquired

  • Cash
  • Accounts receivable

20

slide-21
SLIDE 21

Practice Acquisitions

  • Supply Inventories – normally an estimate

based on industry inventory turnover rates

  • Furniture and Fixtures – Appraisal
  • Trained and Assembled Workforce

– Replacement cost per employee – Industry based % cost for employee turnover – Specific position replacement costs

21

slide-22
SLIDE 22

Practice Acquisitions

  • Challenges in the Industry

– Consideration of the implication of ancillary profits on practice value – Relationship with ongoing compensation – Future profitability of practice (as a subsidiary or dept.

  • f the hospital) and the implications of practice losses

– Commercial reasonableness

22

slide-23
SLIDE 23

What is FMV?

  • Professional services

– The harder you work, the more you make – FMV range centers around Median – Must have justifiable reasons to approach 75th Percentile – Facts and circumstances are needed to support comp/wRVU > Median – Must be commercially reasonable

slide-24
SLIDE 24

FMV Defenses

Multiple Indicators for FMV:

Income Approach

– Profitability of the physician (or lack thereof)

Market Approach

– Total Cash Compensation (TCC) – Compensation per wRVU – TCC as a % of Professional Collections

slide-25
SLIDE 25

Use of Market Data to establish FMV of Physician Compensation

  • Proper understanding and use of survey data

(Compensation per wRVU, TCC as % of Professional Collections ratio, etc.)

  • Reliance on data from multiple surveys versus one

survey

  • What data points are represented/included in

each survey?

  • wRVU data and the “match” to compensation

percentiles

  • Is there a “safe” percentile for compensation –

50th percentile/75th percentile? (recent settlements suggest: perhaps not)

slide-26
SLIDE 26

Industry Data Sources

  • Medical Group Management Association (“MGMA”) -

Physician Compensation and Production Survey

  • American Medical Group Association (“AMGA”) -

Medical Group Compensation and Financial Survey

  • Sullivan Cotter and Associates (“SCA”) - Physician

Compensation and Productivity Survey Report

  • Other Published Industry and Specialty Society Support
  • Market information gained from experience throughout

the country

slide-27
SLIDE 27

Estimated Market Positions:

Family Practice with OB

27

Compensation N Median 75th % 90th %

Family Practice (w/ OB) MGMA 2019 622 268,954 $ 332,594 $ 406,515 $ Family Practice (w/ OB) MGMA 2018 1,030 242,932 $ 309,261 $ 382,482 $ Family Practice With OB AMGA 2019 472 279,148 $ 365,232 $ 405,409 $ Family Practice With OB AMGA 2018 550 263,190 $ 314,734 $ 392,988 $ Family Medicine With Obstetrics SCA 2018 871 254,830 $ 318,387 $ 398,358 $ Family Medicine With Obstetrics SCA 2017 527 245,286 $ 295,917 $ 360,000 $

Estimated Market Position 265,000 $ 335,000 $ 405,000 $

267,644 $ 338,738 $ 403,427 $ 265,142 $ 334,136 $ 402,634 $

WRVUs N Median 75th % 90th %

Family Practice (w/ OB) MGMA 2019 485 4,900 6,343 7,961 Family Practice (w/ OB) MGMA 2018 918 4,819 5,974 7,371 Family Practice With OB AMGA 2019 447 5,048 6,347 7,154 Family Practice With OB AMGA 2018 512 5,063 6,171 7,576 Family Medicine With Obstetrics SCA 2018 554 4,843 5,613 6,806 Family Medicine With Obstetrics SCA 2017 433 4,790 5,749 6,940

Estimated Market Position 4,900 6,200 7,400

4,930 6,101 7,307 4,923 6,072 7,288

Current Year Average Current Year Weighted Average Current Year Average Current Year Weighted Average

slide-28
SLIDE 28

Estimated Market Positions:

Family Practice with OB, cont’d

28 Comp per WRVU N Median 75th %

Family Practice (w/ OB) MGMA 2019 476 55.76 $ 66.94 $ Family Practice (w/ OB) MGMA 2018 901 51.72 $ 62.98 $ Family Practice With OB AMGA 2019 447 55.31 $ 73.91 $ Family Practice With OB AMGA 2018 512 52.18 $ 60.57 $ Family Medicine With Obstetrics SCA 2018 554 54.43 $ 64.78 $ Family Medicine With Obstetrics SCA 2017 433 51.15 $ 60.89 $

Estimated Market Position 55.00 $ 68.00 $

55.17 $ 68.54 $ 55.12 $ 68.24 $

Comp as a % of Collections N Median 75th %

Family Practice (w/ OB) MGMA 2019 86 67.1% 94.6% Family Practice (w/ OB) MGMA 2018 205 79.8% 94.4% Family Practice With OB AMGA 2019 192 63.7% 94.9% Family Practice With OB AMGA 2018 244 63.9% 87.3% Family Medicine With Obstetrics SCA 2018 184 63.7% 84.9% Family Medicine With Obstetrics SCA 2017 125 65.6% 95.1%

Estimated Market Position 65.0% 92.0%

64.8% 91.5% 64.3% 90.9%

Current Year Weighted Average Current Year Average Current Year Average Current Year Weighted Average

slide-29
SLIDE 29

Relationship Between Production and Comp/wRVU

29

75th % wRVUs x 75th % Comp/wRVU ≠ 75th % Compensation

2019 MGMA: Family Practice with OB Median 75th % 90th %

Total Compensation 268,954 $ 332,594 $ 406,515 $ wRVUs 4,900 6,343 7,961 Compensation per wRVU 55.76 $ 66.94 $

Example: "I produce at the 75th percentile; therefore, I should get paid 75th percentile compensation per wRVU." 75th Percentile wRVUs (MGMA) 6,343 75th Percentile Comp/wRVU (MGMA) 66.94 $ 424,600 $ Result: Compensation in excess of reported total compensation at the 75th (and 90th) percentiles.

slide-30
SLIDE 30

Use of Regional Data

  • Issues with Regional Data:

– Lower sample sizes – Data anomalies

30

Comp per WRVU N Median 75th %

Family Practice (w/ OB) MGMA 2019 476 55.76 $ 66.94 $ Family Practice (w/ OB) MGMA 2018 901 51.72 $ 62.98 $ Family Practice With OB AMGA 2019 447 55.31 $ 73.91 $ Family Practice With OB AMGA 2018 512 52.18 $ 60.57 $ Family Medicine With Obstetrics SCA 2018 554 54.43 $ 64.78 $ Family Medicine With Obstetrics SCA 2017 433 51.15 $ 60.89 $ Family Practice (w/ OB) MGMA 2019 - Midwest 320 56.15 $ 67.00 $ Family Practice (w/ OB) MGMA 2018 - Midwest 438 50.42 $ 59.15 $ National Midwest

slide-31
SLIDE 31

Relationship Between Production and Comp/wRVU

31

slide-32
SLIDE 32

Common Compensation Issues for Other Services

  • Medical Directorships
  • Commercial Reasonableness
  • Best Practices
  • Predetermined time requirements/needs
  • Documented time sheets
  • FMV hourly rate
  • Call Coverage
  • Quality Add-ons
  • Outreach
  • Physician Extenders
  • Stacking
slide-33
SLIDE 33

Proposed Regulatory Changes

  • Revisions proposed to definitions of "fair

market value" and "commercial reasonableness" under Stark and AKS

– Fair market value

  • Permits consideration of generally accepted

valuation principles

  • May permit more flexibility based on facts and

circumstances of the provider

33

slide-34
SLIDE 34

Proposed Regulatory Changes

  • Revisions proposed to definitions of "fair

market value" and "commercial reasonableness" under Stark and AKS

– Commercial reasonableness

  • CMS expressly acknowledges that profitability of

an arrangement is not dispositive

  • "Does the arrangement further a legitimate

business purpose of the parties?"

  • Still must be considered in the absence of referrals

34

slide-35
SLIDE 35

Best Practices

  • Engage valuator if anything other than tangible

asset value is to be paid in an acquisition

  • Develop a physician compensation policy

consistent with organization’s goals and values

  • Validate amounts against external studies
  • Periodically review physician compensation with

FMV consultant

  • Separately review compensation of high earners

with FMV consultant more frequently

  • Ensure compensation is not related to volume or

value of referrals

slide-36
SLIDE 36

Best Practices

  • Use objective standards (including incentive

compensation standards) that can be evaluated by a court or arbitrator

  • Board or board committee review

– All elements of compensation – Document executive and board review for reasonableness – Watch for conflicts

  • Evaluate all acquisitions and compensation

arrangements for commercial reasonableness

  • Keep focus on community benefit and

charitable/governmental purpose

slide-37
SLIDE 37

Questions?

Andrew D. Kloeckner Baird Holm LLP akloeckner@bairdholm.com 402.636.8222 Kevin Walker CBIZ kwalker@cbiz.com 816.945.5598